Cigna Corporation
Cigna Corporation (CI) is a healthcare services and insurance company with a $74.9B market cap, showing a structural political alignment with key House health committee members via $5,000 donations to 8 representatives and an evidentiary signal from a $2.0M insider buy by its CEO.
BusinessWhat CI does
Cigna is a global health services organization providing insurance, pharmacy benefit management, and health care delivery services. Its revenue lines include premiums from health insurance plans, fees from pharmacy benefit management, and other health services.
6 months past · 3 months futureCI activity timeline
Executive Branch ConflictsCI held by Trump-administration officials
Lifetime Government AwardsCI federal contracts
CI doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding CI
Politicians Trading CIMembers of Congress with recent CI positions
Congressional TradesWho in Congress is trading CI
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting CILive legislation impacting this stock
Political ProfileWhere CI sits in Washington
[object Object]
STRUCTURAL: Donations to 8 House members, including key health committee roles (Ways and Means Health, Energy and Commerce Health) with $5,000 each. EVIDENTIARY: CEO David Cordani purchased $2.0M in stock on 2025-11-03 per get_corporate_insider_signal.top_buys; executive branch exposure shows Trump holds CI stock in two buckets up to $15,000 per get_executive_branch_exposure.by_ticker. Net: Moderate bullish due to insider buy and committee alignment, but no lobbying spend or strong trading patterns.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Potential legislative changes impacting health insurance and pharmacy benefit management revenueCongress"Multiple healthcare bills with impact_ratio 0.0002 each affecting revenue by ~$12.7M-$13.0M per Recent bill_impacts."
Regulatory opportunities
-
Alignment with House health committee members may influence favorable regulatory outcomesCongress"Donations to members of House Ways and Means Health subcommittee (Evans, Kustoff) and Energy and Commerce Health subcommittee (Balderson, DeGette) per get_political_influence.donations."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Live signals + predictions for CI — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades CI
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord